Back
Pacific Biosciences of California 10K Form
Sell
21
PACB
Pacific Biosciences of California
Last Price:
$1.22
Seasonality Move:
-13.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-09 | 10Q | PACB/Pacific Biosciences of California Quarterly |
| 2024-02-28 | 10K | PACB/Pacific Biosciences of California Annual |
| 2023-11-03 | 10Q | PACB/Pacific Biosciences of California Quarterly |
| 2023-08-04 | 10Q | PACB/Pacific Biosciences of California Quarterly |
| 2023-05-04 | 10Q | PACB/Pacific Biosciences of California Quarterly |
| 2023-02-28 | 10K | PACB/Pacific Biosciences of California Annual |
Receive PACB News And Ratings
See the #1 stock for the next 7 days that we like better than PACB
PACB Financial Statistics
Sales & Book Value
| Annual Sales: | $154M |
|---|---|
| Cash Flow: | $-44.7M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.73 |
| Price / Book: | 0.71 |
Profitability
| EPS (TTM): | -1.64000 |
|---|---|
| Net Income (TTM): | $-308.7M |
| Gross Margin: | $37.3M |
| Return on Equity: | -55.04% |
| Return on Assets: | -20.21% |
Pacific Biosciences of California Earnings Forecast
Key Pacific Biosciences of California Financial Ratios
-
The Gross Profit Margin over the past 18 years for PACB is 24.21%.
-
The Selling, General & Administrative Expenses for PACB have been equal to 113.64% of Gross Profit Margin.
-
The Research & Development expenses have been 87.60% of Revenue.
-
The Net Earning history of PACB is -200.40% of Total Revenues.
-
Per Share Earnings over the last 18 years have been positive in 10 years.
Pacific Biosciences of California Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | PACB |
| CUSIP: | 69404D |
| Website: | pacb.com |
Debt
| Debt-to-Equity Ratio: | 1.28 |
|---|---|
| Current Ratio: | 8.43 |
| Quick Ratio: | 7.08 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PACB Technical Analysis vs Fundamental Analysis
Sell
21
Pacific Biosciences of California (PACB)
is a Sell
Is Pacific Biosciences of California a Buy or a Sell?
-
Pacific Biosciences of California stock is rated a SellThe current Pacific Biosciences of California [PACB] share price is $1.22. The Score for PACB is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.